Pre-Series A in Biotech: How to Plan for Trials, Burn, and Investor Expectations
A plain-English guide for scientific founders navigating clinical costs and capital strategy.
February 17, 2026 • 12 PM (PST)
Live on Zoom • Free Registration
Raise too little and run out of runway.
Ask for too much and fail to raise.
If you’re a biotech founder, you’ve probably wrestled with this at 2 AM.
In this 45-minute webinar, experts from Primum Law Group and Moxie Clinical Inc. will break down what founders need to know—in plain English—about aligning your raise, burn, and trial roadmap so you can go into investor conversations with clarity and confidence.
This Is For You If:
You’re a scientific founder or CxO at a biotech or medtech startup
You’re raising a pre-seed, seed, or Series A round
You’re planning for preclinical, IND, or Phase I trials
You want plain-English answers about burn, timeline, and valuation
You need to translate your science into a credible capital plan
In this 45-minute webinar, experts from Primum Law Group and Moxie Clinical Inc. will break down what founders need to know—in plain English—about aligning your raise, burn, and trial roadmap so you can go into investor conversations with clarity and confidence.
We’ll Cover:
How to map your raise to actual clinical timelines and cash needs
Why under-raising is riskier than founders realize
How investors view your trial assumptions, burn rate, and valuation
What to include (and explain) in your data room
How to structure the round to stay founder-friendly
What You’ll Get:
Clarity on the trial process and what it really costs
Confidence in talking with investors about financial and clinical strategy
First-hand insights from a clinical strategist and startup counsel
A founder-focused lens on diligence, dilution, and data rooms
Access to the recorded session and slides
Expert Speakers:
Svetlana Kamyshanksaya Pantelic
Founder of Primum Law Group
An international business lawyer specializing in cross-border legal strategy, Svetlana helps startups and growth-stage companies navigate complex global regulations with precision and clarity.
